Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

395 ARTÍCULOS , VIENDO DEL 256 AL 270

Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forward

Alber J, Goldfarb D, Thompson LI, Arthur E, Hernandez K, Cheng D, DeBuc DC, Cordeiro F, Provetti-Cunha L, den Haan J, Van Stavern GP, Salloway SP, Sinoff S, Snyder PJ.

Alzheimers Dement. 2020 Jan;16(1):229-243. doi: 10.1002/alz.12006.

Blood-based Biomarkers of Alzheimer's Disease: The Long and Winding Road

Manzine PR, Vatanabe IP, Peron R, Grigoli MM, Pedroso RV, Nascimento CMC, Cominetti MR.

Curr Pharm Des. 2020;26(12):1300-1315. doi: 10.2174/1381612826666200114105515.

Sex and gender differences in Alzheimer's disease: current challenges and implications for clinical practice: Position paper of the Dementia and Cognitive Disorders Panel of the European Academy of Neurology

Ferretti MT, Martinkova J, Biskup E, Benke T, Gialdini G, Nedelska Z, Rauen K, Mantua V, Religa D, Hort J, Santuccione Chadha A, Schmidt R.

Eur J Neurol. 2020 Jun;27(6):928-943. doi: 10.1111/ene.14174. Epub 2020 Apr 3.

18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease

Okafor M, Nye JA, Shokouhi M, Shaw LM, Goldstein F, Hajjar I.

J Alzheimers Dis. 2020;74(2):589-601. doi: 10.3233/JAD-191330.

Interactions between Personality, Depression, Anxiety and Cognition to Understand Early Stage of Alzheimer's Disease

Zufferey V, Gunten AV, Kherif F.

Curr Top Med Chem. 2020;20(9):782-791. doi: 10.2174/1568026620666200211110545.

Genetic Variants and Oxidative Stress in Alzheimer's Disease

Kowalska M, Wize K, Prendecki M, Lianeri M, Kozubski W, Dorszewska J.

Curr Alzheimer Res. 2020;17(3):208-223. doi: 10.2174/1567205017666200224121447.

The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease

Colom-Cadena M, Spires-Jones T, Zetterberg H, Blennow K, Caggiano A, DeKosky ST, Fillit H, Harrison JE, Schneider LS, Scheltens P, de Haan W, Grundman M, van Dyck CH, Izzo NJ, Catalano SM; Synaptic Health Endpoints Working Group.

Alzheimers Res Ther. 2020 Mar 2;12(1):21. doi: 10.1186/s13195-020-00588-4.

Medical Histories of Control Subjects Influence the Biomarker Potential of Plasma Aβ in Alzheimer's Disease: a Meta-analysis

Zhang S, Huang SY, An XB, Zeng L, Ai J.

J Mol Neurosci. 2020 Jun;70(6):861-870. doi: 10.1007/s12031-020-01510-1. Epub 2020 Mar 3.

Use of ocular biomarkers as a potential tool for early diagnosis of Alzheimer's disease

Singh AK, Verma S.

Indian J Ophthalmol. 2020 Apr;68(4):555-561. doi: 10.4103/ijo.IJO_999_19.

Biochemical Markers in Alzheimer's Disease

Rabbito A, Dulewicz M, Kulczyńska-Przybik A, Mroczko B.

Int J Mol Sci. 2020 Mar 14;21(6):1989. doi: 10.3390/ijms21061989.

The evaluation of thiol-disulfıte balance, ischemıa albumın modıfıcation and seruloplazmine as a new oxidatıve stress in mild cognitive impairment and early stage alzheimer's disease patients

Gündüztepe Y, Bukan N, Zorlu E, Karaman Y, Andaç Topkan T, Gurbuz N, Neşelioğlu S, Erel Ö.

J Clin Neurosci. 2020 May;75:188-194. doi: 10.1016/j.jocn.2019.12.026. Epub 2020 Mar 27.

Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease

Janelidze S, Stomrud E, Smith R, Palmqvist S, Mattsson N, Airey DC, Proctor NK, Chai X, Shcherbinin S, Sims JR, Triana-Baltzer G, Theunis C, Slemmon R, Mercken M, Kolb H, Dage JL, Hansson O.

Nat Commun. 2020 Apr 3;11(1):1683. doi: 10.1038/s41467-020-15436-0.

Alzheimer's disease beyond amyloid: Can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery?

Mullane K, Williams M.

Biochem Pharmacol. 2020 Jul;177:113945. doi: 10.1016/j.bcp.2020.113945. Epub 2020 Apr 2.

Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study

Lopes Alves I, Collij LE, Altomare D, Frisoni GB, Saint-Aubert L, Payoux P, Kivipelto M, Jessen F, Drzezga A, Leeuwis A, Wink AM, Visser PJ, van Berckel BNM, Scheltens P, Gray KR, Wolz R, Stephens A, Gismondi R, Buckely C, Gispert JD, Schmidt M, Ford L, Ritchie C, Farrar G, Barkhof F, Molinuevo JL; AMYPAD Consortium.

Alzheimers Dement. 2020 May;16(5):750-758. doi: 10.1002/alz.12069. Epub 2020 Apr 12.

New fluid biomarkers tracking non-amyloid-β and non-tau pathology in Alzheimer's disease

Park SA, Han SM, Kim CE.

Exp Mol Med. 2020 Apr;52(4):556-568. doi: 10.1038/s12276-020-0418-9. Epub 2020 Apr 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias